<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="http://articles.mercola.com/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Beware Another Vioxx-Like Drug Still on Market</title><link>http://articles.mercola.com/sites/articles/archive/2006/09/28/beware-another-vioxx-like-drug-still-on-market.aspx</link><description>Merck's arthritis drug Arcoxia, developed in order to compete with Celebrex, may hold as many risks for the heart as the notorious drug Vioxx, according to FDA whistleblower David Graham. Graham rose to national prominence two years ago when he informed</description><dc:language>en</dc:language><generator>CommunityServer 2008.5 SP1 (Build: 31106.3070)</generator></channel></rss>